newsfilter
← Latest News
GlobeNewswire·

Alps Group Appoints Former Ernst & Young Partner to Board of Directors, Strengthening Governance and Capital Markets Oversight

ALPS
  • Alps Group Inc appointed Mr. Hee H. Lee to its Board of Directors effective April 17, 2026.
  • The Board will expand from five to six members following this appointment.
  • Mr. Lee is classified as an independent director under Nasdaq rules.
  • He will serve on the Audit Committee & the Compensation Committee.
  • Mr. Lee possesses over 35 years of experience in public accounting & advisory services.
  • He previously served as a Partner at Ernst & Young LLP within the Global Financial Services Organization.
  • He established & led the Americas Financial Accounting Advisory Services practice at EY.
  • His expertise spans asset management, banking, insurance, private equity, & fintech/digital assets.
  • He has advised on derivatives, securitization, structured financing, IPOs, & mergers and acquisitions.
  • Mr. Lee served as an advisor to the International Swaps and Derivatives Association for over 20 years.
  • He is a Certified Public Accountant licensed in New York & a member of the American Institute of Certified Public Accountants.
  • Mr. Lee holds a Master of Accountancy & Financial Information Systems from Cleveland State University.
  • He holds a Bachelor of Business Administration from the University of Louisiana at Lafayette.
  • He completed executive education programs in board & leadership development at Harvard University & the Kellogg School of Management.
  • CEO Dr. Tham Seng Kong stated Mr. Lee's experience will strengthen Board oversight & support the Company's development as a public entity.
  • Mr. Lee expressed pleasure in joining the Board to contribute to the Company's strategic direction & governance framework.
  • Alps Group Inc is the parent company of Alps Life Sciences Inc., a biotechnology platform focused on predictive, preventive, & precision medicine.
  • The Company's mission is to create a fair healthcare ecosystem making advanced medicine accessible & affordable.
  • The press release includes standard forward-looking statements disclaimers regarding future events & risks.
  • Investor relations inquiries can be directed to investorrelations@alpsmedical.com.